Invention Grant
- Patent Title: Crystalline polymorphs of Rivoceranib and Rivoceranib mesylate
-
Application No.: US17269290Application Date: 2019-09-04
-
Publication No.: US11434202B2Publication Date: 2022-09-06
- Inventor: Anantha Rajmohan Muthusamy , Sundara Lakshmi Kanniah , Elluru Subbireddy
- Applicant: ASSIA CHEMICAL INDUSTRIES LTD.
- Applicant Address: IL Petach Tikva
- Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
- Current Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
- Current Assignee Address: IL Petach Tikva
- Agency: Carter, DeLuca & Farrell LLP
- Priority: IN201811033405 20180905,IN201811039438 20181017,IN201911022155 20190604
- International Application: PCT/US2019/049434 WO 20190904
- International Announcement: WO2020/051173 WO 20200312
- Main IPC: C07D213/82
- IPC: C07D213/82
Abstract:
The present disclosure encompasses crystalline polymorphs of Rivoceranib and Rivoceranib mesylate (Apatinib mesylate), processes for preparation thereof, and pharmaceutical compositions thereof.
Public/Granted literature
- US20210253529A1 NEW CRYSTALLINE POLYMORPHS OF RIVOCERANIB AND RIVOCERANIB MESYLATE Public/Granted day:2021-08-19
Information query
IPC分类:
